Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Activity-dependent neuroprotective protein (ADNP)–End-binding protein (EB) complex is a vital protein-protein interaction assembly that regulates microtubule dynamics and stability in neurons. ADNP, a protein essential for brain development, contains a SIP (Ser-Ile-Pro) motif—a variant of the SxIP motif—which mediates its binding to the C-terminal domains of EB1 and EB3 proteins at the plus-ends of microtubules (Oz et al., 2014; Ivashko-Pachima et al., 2017). This interaction is fundamental for axonal transport, dendritic spine density, and overall synaptic plasticity. Disruptions in this complex are linked to neurodegenerative conditions like Alzheimer's disease and neurodevelopmental disorders such as ADNP syndrome (Helsmoortel-Van der Aa syndrome), which is characterized by autism and intellectual disability (Helsmoortel et al., 2014; Gozes, 2011). The therapeutic peptide Davunetide (NAP) is derived from ADNP and contains the SIP motif, allowing it to mimic and stabilize the ADNP-EB interaction. By promoting microtubule-dependent transport and protecting against microtubule disassembly, this complex serves as a key target for neuroprotective interventions (Gozes et al., 2014).
Stabilization of the ADNP-EB interaction to enhance microtubule dynamics and protect against tau-related pathology.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activity-dependent neuroprotective protein–End-binding protein complex (ADNP–EB1/EB3 complex).